The Counterfeit Detection Device #3, or CD3, is a handheld device. It emits wavelengths of light that can be used on tablets and capsules, powders and packaging, according to the report. It is designed to perform real-time comparisons with authentic drugs. It is intended to detect tampered, re-labeled or re-glued products.
The CD3 is currently in use at FDA field laboratories, border crossings, import centers and international mail facilities.
Related Articles on FDA:
Recall Issued for Anesthesia Pump with ONDEMAND Bolus Button
Covidien Receives FDA Clearance of Small Jaw Instrument for ENT Surgical Procedures
Precision Spine Receives FDA Clearance for Anterior Cervical Plate System
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.